Dow Jones futures fell slightly overnight, along with S&P 500 futures and Nasdaq futures. Big earnings from JPMorgan, Bank of America, UnitedHealth, Delta Air Lines and more are on tap Friday morning.
The stock market rally gained some more ground on Thursday, though the S&P 500 hit resistance at a critical area.
The much-anticipated CPI inflation report showed cooling price pressures largely in line with expectations, though service price gains were a mixed picture. Still, the slowing inflation trend should continue for several months, raising hopes that the Federal Reserve will soon end rate hikes.
Investors should be looking to add exposure, carefully. This market is prone to pullbacks, and could be due for one. Meanwhile, many leading stocks are now extended from at least early buy points. Exxon Mobil (XOM) and Celsius Holdings (CELH) are still actionable.
XOM stock and Celsius are on the IBD 50. CELH stock is on SwingTrader and on the IBD Leaderboard watchlist.
JPMorgan Chase (JPM), Wells Fargo (WFC), Bank of America (BAC), Citigroup (C) all report Friday morning. UnitedHealth (UNH) and Delta Air Lines (DAL) kick off earnings for their respective groups.
JPMorgan stock is in a buy zone after a traditional breakout. Bank of America and Citigroup stock are near early entries in bottoming bases. WFC stock has more work to do. UNH stock has sold off in 2023 along with other health insurers, though it rose Thursday. DAL stock has spiked in 2023 with the airline group, adding to gains on bullish preliminary revenue from American Airlines (AAL). But Delta is well extended from early entries and is working up the right side of a long, deep base.
JPM stock and UnitedHealth are both Dow Jones components.
Dow Jones futures fell 0.1% vs. fair value, with S&P 500 futures declined 0.2%. Nasdaq 100 futures fell 0.4%.
The 10-year Treasury yield rose 2 basis points to 3.47%.
Remember that overnight action in Dow futures and elsewhere doesn't necessarily translate into actual trading in the next regular stock market session.
Join IBD experts as they analyze actionable stocks in the stock market rally on IBD Live
The stock market rally wavered Thursday, with volatile premarket swings continuing into the morning. But as the session wore on, the major indexes calmed down and moved higher before fading somewhat in the day.
The Dow Jones Industrial Average advanced 0.6% in Thursday's stock market trading. The S&P 500 index climbed 0.3%. The Nasdaq composite rose 0.6%. The small-cap Russell 2000 jumped 1.7%.
U.S. crude oil prices rose 1.3% to $78.39 a barrel, climbing 7.6% over the past six sessions.
Copper climbed 0.8% on Thursday, surging 11.9% over the past six trading days.
The 10-year Treasury yield tumbled 11 basis points to 3.45%, near recent lows. The two-year Treasury yield, more closely tied to Fed policy, hit a three-month low. Markets have almost fully priced in a quarter-point rate hike on Feb. 1, which would be a step down from 50 basis points and 75 basis points in the prior two meetings. Investors also strongly expect another quarter-point hike in March, to a 4.75%-5% range. Right now, markets are betting that's the end.
Time The Market With IBD's ETF Market Strategy
Among growth ETFs, the Innovator IBD 50 ETF (FFTY) and Innovator IBD Breakout Opportunities ETF (BOUT) rose 0.7%. The iShares Expanded Tech-Software Sector ETF (IGV) climbed 0.8%. The VanEck Vectors Semiconductor ETF (SMH) climbed 1.5%.
SPDR S&P Metals & Mining ETF (XME) jumped 2% and the Global X U.S. Infrastructure Development ETF (PAVE) rose 0.8%. U.S. Global Jets ETF (JETS) soared 4.6%, with DAL stock and American Air both key holdings. SPDR S&P Homebuilders ETF (XHB) edged up 0.3%. The Energy Select SPDR ETF (XLE) advanced 1.9%. The Financial Select SPDR ETF (XLF) nudged 0.2% higher, with JPMorgan, Wells Fargo, Citigroup and BAC stock all major components. The Health Care Select Sector SPDR Fund (XLV) dipped 0.3%, with UNH stock a major holding.
Reflecting more-speculative story stocks, ARK Innovation ETF (ARKK) popped 2.1% and ARK Genomics ETF (ARKG) 3.45%.
Five Best Chinese Stocks To Watch Now
After wavering in the morning, the major indexes ultimately climbed modestly, while small caps jumped.
The S&P 500 came right up to its 200-day moving average, closing just below that key level. The Nasdaq held support at its 50-day line and moved a little higher from that area.
The Dow Jones and Russell 2000, above all their moving averages, are working toward their December highs.
Overall, the market rally has made huge strides over the past five sessions. Investors see the light at the end of the tunnel for Fed rate hikes.
Still, the major indexes face further tests. The S&P 500 needs to decisively clear the 200-day line, where it's hit resistance multiple times. The December highs are the ultimate test for the indexes. But after running up for several sessions, with the major indexes right around key levels, a pause or pullback wouldn't be a surprise.
Leading stocks are showing better action, but many are now extended, at least from early entries or moving averages.
Exxon Mobil stock rose 1.7% to 113.22, just below a 114.76 flat-base buy point, according to MarketSmith analysis. But XOM stock is in range from the 50-day line. Celsius stock dipped 0.2% to 106.40, but found support at the 21-day line. CELH stock is still actionable from Wednesday's jump, rebounding from the 50-day line and breaking a short trendline.
In a positive sign for the broader market rally, the chip sector has regained momentum, with the SMF ETF moving decisively above its 200-day line this week. Taiwan Semiconductor (TSM), the largest holding in SMH, gapped above its 200-day line on earnings. That's despite revenue falling short and TSMC also guiding low on Q1. But not many chip names, even those that are clear market leaders, are actionable right now.
Tesla Vs. BYD: EV Giants Vie For Crown, But Which Is The Better Buy?
The stock market rally has had a strong stretch, moving above some key resistance areas and with the CPI inflation report out of the way.
Investors can be adding exposure, gradually, if conditions continue to improve. The major indexes, sectors and leading stocks have had a tendency to stage big pullbacks just as they seem to be gaining steam. And the market rally is gaining momentum.
Earnings season could upend the market rally, or slam specific sectors or stocks.
Investors who largely stayed on the sidelines in recent days may feel like big opportunities have passed them by. It's true that some stocks may be out of reach right now. But don't chase extended names. Wait to see if they pause or pull back or set up new bases. Meanwhile, other stocks will come to the fore.
If this market rally has real legs, that there will plenty of chances. If it quickly stalls out again, then you'll be glad you're not heavily invested.
But it's crucial to have your watchlists up to date. Cast a wide net to find stocks that are setting up across different sectors. Then focus on stocks that are "ready" or nearly so.
Read The Big Picture every day to stay in sync with the market direction and leading stocks and sectors.
Please follow Ed Carson on Twitter at @IBD_ECarson for stock market updates and more.
YOU MAY ALSO LIKE:
Why This IBD Tool Simplifies The Search For Top Stocks
Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader
Best Growth Stocks To Buy And Watch
IBD Digital: Unlock IBD's Premium Stock Lists, Tools And Analysis Today
10:16 AM ET Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are...
10:16 AM ET Buying a stock is easy, but buying the right stock...
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.
Comments
0 comment